Idiopathic Thrombocytopenic Purpura. Idiopathic Thrombocytopenic Purpura
Conditions
Interventions
Intervention 1: In the intervention group, Medicago Sativa syrup containing 650 mg of extract of alfalfa in each 5 ml and daily intake of patients is 5 ml every eight hours. Intervention 2: The contro
Treatment - Drugs
In the intervention group, Medicago Sativa syrup containing 650 mg of extract of alfalfa in each 5 ml and daily intake of patients is 5 ml every eight hours.
The control group will be received 5 ml placebo syrup is administered every eight hours.
Sponsors
Research and Technology Vice-Chancellory of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: the definitive diagnosis of ITP resistant to corticosteroids or corticosteroid dependent by an expert hematologist; platelet count between 50,000 to 150,000; aged between 15 and 50 years; lack of spontaneous bleeding; lack of other blood diseases; lack of systemic disease such as lupus erythematosus; lack of pregnancy; desire to attend the project Exclusion criteria: an active and spontaneous bleeding; need to hospitalization; thrombocytopenia below 50,000; infectious disease; pregnancy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet count. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complete Blood Count. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.;Bleeding Time. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamideh Naghedi Baghdar
Faculty of Iranian Traditional Medicine of Mashhad University of Medical Sciences
Outcome results
None listed